(Q44205471)

30 November 2017

title

Analytical and pharmacokinetic studies with 5-chloro-2'-deoxycytidine (English)

1 reference

30 November 2017

1 reference

JodiAnne T Hale

1

1 reference

30 November 2017

James C Bigelow

series ordinal

2

1 reference

30 November 2017

Linda A Mathews

series ordinal

3

1 reference

30 November 2017

John J McCormack

series ordinal

4

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

published in

Biochemical Pharmacology

1 reference

30 November 2017

volume

64

1 reference

30 November 2017

issue

10

1 reference

30 November 2017

page(s)

1493-1502

1 reference

Radiobiology and clinical application of halogenated pyrimidine radiosensitizers

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901413-2

Radiation, pool size and incorporation studies in mice with 5-chloro-2'-deoxycytidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901413-2

Selective radiosensitization and cytotoxicity of human melanoma cells using halogenated deoxycytidines and tetrahydrouridine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901413-2

Sensitization to X ray by 5-chloro-2'-deoxycytidine co-administered with tetrahydrouridine in several mammalian cell lines and studies of 2'-chloro derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901413-2

Five-chlorodeoxycytidine and biomodulators of its metabolism result in fifty to eighty percent cures of advanced EMT-6 tumors when used with fractionated radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901413-2

Inhibition of cytidine deaminase by 2-oxopyrimidine riboside and related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901413-2

5-chlorodeoxycytidine, a radiosensitizer effective against RIF-1 and Lewis lung carcinoma, is also effective against a DMBA-induced mammary adenocarcinoma and the EMT-6 tumor in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901413-2

Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901413-2

Pharmacokinetics of N4-octadecyl-1-beta-D-arabinofuranosylcytosine in plasma and whole blood after intravenous and oral administration to mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901413-2

Antitumor properties of 2(1H)-pyrimidinone riboside (zebularine) and its fluorinated analogues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901413-2

Distribution of cyclocytidine in tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901413-2

Purification and characterization of uridine and thymidine phosphorylase from Lactobacillus casei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901413-2

Continuous spectrophotometric assay of thymidine phosphorylase using 5-nitro-2'-deoxyuridine as substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901413-2

Thymidine phosphorylase. Substrate specificity for 5-substituted 2'-deoxyuridines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901413-2

Uridine phosphorylase from Escherichia coli. Kinetic properties and mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901413-2

10.1016/S0006-2952(02)01413-2

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference